First human test of new eye drug for blinding condition
NCT ID NCT07230834
Summary
This is an early-stage study testing the safety of an experimental drug called pozelimab, given as an injection into the eye. It involves about 54 people with geographic atrophy, a condition that causes progressive vision loss. The main goal is to see how well people tolerate the injection and to check for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY (GA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Austin Retina Associates
RECRUITINGAustin, Texas, 78705, United States
-
Colorado Retina Associates
RECRUITINGLakewood, Colorado, 80228, United States
-
Ophthalmic Consultants of Boston
RECRUITINGEast Weymouth, Massachusetts, 02189, United States
-
Retina Consultants Texas
RECRUITINGThe Woodlands, Texas, 77384, United States
Conditions
Explore the condition pages connected to this study.